HOB Biotech Group Corp (688656.SS) Stock Price

HOB Biotech Group Corp Price

CLOSED
116.85
​
Market closed

Revenue has compounded at 15.2% per year over the past 9 years to 398.40 M CNY. Earnings per share have grown at 20.5% per year over the last 9 years. HOB Biotech Group Corp's net margin stands at 5.8%, down from 27.1% several years earlier. HOB Biotech Group Corp currently offers a dividend yield of about 0.26%. The payout ratio is around 85% of earnings.

HOB Biotech Group Corp stock price

Access this data via the Eulerpool API

HOB Biotech Group Corp business model & stock analysis

HOB Biotech Group Corp. Ltd. engages in the research and development, production, and sale of in-vitro diagnostic reagents. The company is headquartered in Suzhou, Jiangsu and currently employs 488 full-time employees. The company went IPO on 2021-01-13. The firm provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. The company is also engaged in the provision of reagent supporting testing instruments and others. The firm conducts its businesses in the domestic market.

Frequently asked questions about HOB Biotech Group Corp

6 analysts currently rate the HOB Biotech Group Corp stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect HOB Biotech Group Corp to generate revenue of 418.00 M CNY and earnings per share of 0.52 CNY.

Converted at the current exchange rate, the HOB Biotech Group Corp share trades at 15.53 EUR (116.85 CNY).

The expected revenue of HOB Biotech Group Corp is 418.00 M CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of HOB Biotech Group Corp is 34.28 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of HOB Biotech Group Corp is currently 225.33. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the HOB Biotech Group Corp stock.

The price-to-sales ratio (P/S) of HOB Biotech Group Corp is currently 18.48. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the HOB Biotech Group Corp stock.

The Eulerpool Quality Score for HOB Biotech Group Corp is 4/10.

The ISIN of HOB Biotech Group Corp is CNE100004C37. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of HOB Biotech Group Corp is 688656.SS. The ticker symbol is used to trade HOB Biotech Group Corp shares on the stock exchange.

Fair ValueTerminal
104.00 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
816,392.99 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Jan 13, 2021
ISIN
CNE100004C37
Cusip
Y3R3HL107
Market capitalization
7.42 B CNYMid Cap
52-Week Range
PEG
17.52
P/E ratio
P/Ee 2026
216.39
P/Ee 2027
162.29
P/Ee 2028
128.41
P/Se
18.48
EV/EBIT
275.82
P/B Ratio
9.05
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
2.68 %
Dividend
Dividend yield
0.26 %
Est. Dividend Yield
0.17 %
Payout Ratio
85.48 %
Dividend growth Ø5Y
-17.71 %
Dividend payments per year
1
Dividend paid since
5 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 9, 2026, 11:41 AM

HOB Biotech Group Corp Peer Group

HOB Biotech Group Corp FIGI

688656:CH · BBG00DSSCG64688656:CG · BBG00NZ2ZZ37